MedPath

A STUDY HELD TO SEE THE EFFECT OF NIMBADI BIDALAKA IN THE MANAGEMENT OF KRIMIGRANTHI (BLEPHARITIS)

Phase 2
Conditions
Health Condition 1: H010- Blepharitis
Registration Number
CTRI/2023/03/050424
Lead Sponsor
Kirti Kailasrao Sengaonkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 The Patients presenting sign and symptoms of

Krimigranthi with Itching of eyelids Burning sensation Lacrimation and white scales along the base of eyelashes

2 Between the age group 18 to 60 years

Exclusion Criteria

1 Blepharitis associated with conjunctivitis and

Ulcerative Blepharitis

2 Patients suffering from Ptosis Psoriasis Drug induced Blepharitis

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
imbadi Bidalaka is effective in the management of Krimigranthi (Blepharitis).Timepoint: 5 days with 2 follow up (0th day and 6th day)
Secondary Outcome Measures
NameTimeMethod
There is significant effect of Nimbadi Bidalaka on Krimigranthi (Blepharitis )Timepoint: 5 days with 2 follow ups (0th day and 6th day)
© Copyright 2025. All Rights Reserved by MedPath